Filter Results:
(2,896)
Show Results For
- All HBS Web
(2,896)
- People (14)
- News (1,082)
- Research (1,307)
- Events (8)
- Multimedia (41)
- Faculty Publications (492)
Show Results For
- All HBS Web
(2,896)
- People (14)
- News (1,082)
- Research (1,307)
- Events (8)
- Multimedia (41)
- Faculty Publications (492)
- October 12, 2017
- Other Article
A Survey of How 1,000 CEOs Spend Their Day Reveals What Makes Leaders Successful
By: Oriana Bandiera, Raffaella Sadun, Andrea Prat and Stephen Hansen
Bandiera, Oriana, Raffaella Sadun, Andrea Prat, and Stephen Hansen. "A Survey of How 1,000 CEOs Spend Their Day Reveals What Makes Leaders Successful." H03Y2R. Harvard Business Review (website) (October 12, 2017).
- September 2022
- Article
Giving a Buck or Making a Buck? Donations by Pharmaceutical Manufacturers to Independent Patient Assistance Charities
By: Leemore Dafny, Christopher Ody and Teresa Rokos
The federal Anti-Kickback Statute prohibits biopharmaceutical manufacturers from directly covering Medicare enrollees’ out-of-pocket spending for the drugs they manufacture, but manufacturers may donate to independent patient assistance charities and earmark donations... View Details
Keywords: Cost Sharing; Prescription Drugs; Drug Spending; Medicare; Dual Eligibility; Cost; Health Care and Treatment; Philanthropy and Charitable Giving; Pharmaceutical Industry
Dafny, Leemore, Christopher Ody, and Teresa Rokos. "Giving a Buck or Making a Buck? Donations by Pharmaceutical Manufacturers to Independent Patient Assistance Charities." Health Affairs 41, no. 9 (September 2022).
- 08 Jun 2015
- Working Paper Summaries
Physician Beliefs and Patient Preferences: A New Look at Regional Variation in Health Care Spending
- March 18, 2021
- Article
How to Build a Life: Here's 10,000 Hours. Don't Spend It All in One Place.
By: Arthur C. Brooks
Brooks, Arthur C. "How to Build a Life: Here's 10,000 Hours. Don't Spend It All in One Place." The Atlantic (March 18, 2021).
- 2018
- Working Paper
Two Hundred Years of Health and Medical Care: The Importance of Medical Care for Life Expectancy Gains
By: Maryaline Catillon, David Cutler and Thomas Getzen
Using two hundred years of national and Massachusetts data on medical care and health, we examine how central medical care is to life expectancy gains. While common theories about medical care cost growth stress growing demand, our analysis highlights the importance of... View Details
Keywords: Mortality; Life Expectancy; Medical Care; Productivity; Public Health; Healthcare Spending; Spending Per Year Of Life Gained; Personal Medicine; Technophysio Evolution; Health; Economics; Health Care and Treatment; Spending; Data and Data Sets; Health Industry
Catillon, Maryaline, David Cutler, and Thomas Getzen. "Two Hundred Years of Health and Medical Care: The Importance of Medical Care for Life Expectancy Gains." NBER Working Paper Series, No. 25330, December 2018.
- 2017
- Working Paper
Malleable Monopoly Money: Does How You Pay For A Gift Card Affect How You Spend It?
By: Priya Raghubir and Shelle Santana
This research examines the malleability of a specific form of “monopoly” money (viz., Raghubir and Srivastava 2008), gift cards, and shows that the manner in which one purchases a gift card affects its subjective value and subsequent use. Study 1 shows that... View Details
- Article
Common Variants of the Oxytocin Receptor Gene Do Not Predict the Positive Mood Benefits of Prosocial Spending
By: Ashley V. Whillans, Lara B. Aknin, Colin Ross, Lihan Chen and Frances S. Chen
Who benefits most from helping others? Previous research suggests that common polymorphisms of the oxytocin receptor gene (OXTR) predict whether people behave generously and experience increases in positive mood in response to socially-focused experiences in daily... View Details
Keywords: Prosocial Behavior; Positivity; Behavior Genetics; Individual Differences; Behavior; Emotions; Genetics; Spending
Whillans, Ashley V., Lara B. Aknin, Colin Ross, Lihan Chen, and Frances S. Chen. "Common Variants of the Oxytocin Receptor Gene Do Not Predict the Positive Mood Benefits of Prosocial Spending." Emotion 20, no. 5 (August 2020): 734–749.
- August 2018
- Article
The Impact of the Entry of Biosimilars: Evidence from Europe
By: Fiona M. Scott Morton, Ariel Dora Stern and Scott Stern
Biologics represent a substantial and growing share of the U.S. drug market. Traditional “small molecule” generics quickly erode the price and share of the branded product upon entry; however, only a few biosimilars have been approved in the U.S. since 2015, thereby... View Details
Keywords: Health Care; Biosimilars; Biologics; Pharmaceutical Competition; Healthcare Spending; Innovation; Health Care and Treatment; Spending; Market Entry and Exit; Competition; Innovation and Invention; Pharmaceutical Industry; United States; Europe
Scott Morton, Fiona M., Ariel Dora Stern, and Scott Stern. "The Impact of the Entry of Biosimilars: Evidence from Europe." Review of Industrial Organization 53, no. 1 (August 2018): 173–210.
- July 1, 2018
- Editorial
The IRS Can Save American Health Care: Letting Workers Spend Pretax Dollars on Insurance Would Do a Lot—Without Requiring Congress to Act
By: Regina E. Herzlinger and Joel Klein
Herzlinger, Regina E., and Joel Klein. "The IRS Can Save American Health Care: Letting Workers Spend Pretax Dollars on Insurance Would Do a Lot—Without Requiring Congress to Act." Wall Street Journal (online) (July 1, 2018).